The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zudin A.M.

Tsentral'naia klinicheskaia bol'nitsa #2 im. N.A. Semashko OAO "RZhD", Moskva

Gritsenko A.G.

Gritsenko Medico-Engineering Research Center, Moscow

Hadzhishvili I.T.

Department of Hospital Surgery with the course of pediatric surgery, Medical Faculty of Russian People’s Friendship University, Moscow

The effects of diosmin and hesperidin on capillary blood flow of upper limbs in patients with secondary Raynaud’s syndrome

Authors:

Zudin A.M., Gritsenko A.G., Hadzhishvili I.T.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2017;(5): 60‑66

Read: 4669 times


To cite this article:

Zudin AM, Gritsenko AG, Hadzhishvili IT. The effects of diosmin and hesperidin on capillary blood flow of upper limbs in patients with secondary Raynaud’s syndrome. Pirogov Russian Journal of Surgery. 2017;(5):60‑66. (In Russ.)
https://doi.org/10.17116/hirurgia2017560-66

Recommended articles:

References:

  1. Mahmood, Levy; Vasan, Wang. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (fee required). Lancet. 2013;27(9921):61752-61753. doi:10.1016/S0140-6736(13)61752-3
  2. Raynaud AGM. De l’asphyxie locale et de la gangrène symétrique des extrémités. Doctoral thesis, published February 25, 1862. Paris: Rignoux. L. Leclerc, Libraire-Éditeur. Also, Paris, Rignoux; 1867.
  3. Perli PD, Pupurinya IYa. Raynaud’s disease. Riga: Zinatne; 1980. (In Russ.).
  4. Kovalenko VN. Rheumatic diseases: diagnostic criteria and treatment programs. Kiev: Zdorovie; 1999. (In Russ.).
  5. Denton CP, Bunce TD, Darado MB, et al. Rheumatology. 1999;38:309.
  6. Brand FN, Larson MG, Kannel WB, et al. Vasc Med. 1997;2:296.
  7. Bartelink ML, Wollersheim H, Leesmans E, et al. Eur Heart J. 1993;14:614.
  8. Cerinic MM, Generini S, Pignone A. Curr Opin Rheumatol. 1998;10:91.
  9. Scherbakov AB, Guseva NG. Terapevticheskiy arkhiv. 1990;5:75. (In Russ.).
  10. Nasonova VA, Bunchuk NV. Rheumatic diseases. M.: Medicina. 1997. (In Russ.).
  11. Grassi W, De Angelis R, Lapadula G, et al. Rheumatol Int. 1998;18:17.
  12. Coffman JD. Curr Treat Opt Cardiovasc Med. 2000;2:219.
  13. Guseva NG, Gritsman NN, Sysoev VF. Terapevticheskiy arkhiv. 1983;7:7. (In Russ.).
  14. Torley H, Madhok R, Cappell H et al. Ann Rheum Dis. 1991;50:804.
  15. Challenor VF. Drugs. 1994;48.864.
  16. Cutolto M. Raynoud phenomenon: capillaroscopy effects. XIII International Congress of rheumatology. Genova, Italy. 2010.
  17. Veverková L, Kalac J, Jedlicka V, Wechsler J. (August 2005). Analysis of surgical procedures on the vena saphena magna in the Czech Republic and an effect of Diosmin and Gesperidin during its stripping (Czech). Rozhl Chir. 84(8):410-412, 414-416.
  18. Danielsson G, Jungbeck C, Peterson K, Norgren L. (January 2002). A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 23(1):73-76. doi:10.1053/ejvs.2001.1531
  19. Steinbruch М, Geller М, Kaufman R, et al. Use of Pure Diosmin in Chronic Venous Disease: A Review of the Literature. Revista Brasileira de Medicina. 2015;72:7:307-314.
  20. Zasorin AA, Makarova NP, Naritzina VV. The effect of diosmin on the microcirculation in slowly granulating wounds. Phlebologiya. 2011;1:12-15. (In Russ.).
  21. Coffman JD, Cardiovasc. Drugs Ther. 1990;4:45.
  22. Kozlov VI. Capillaroscopy in clinic practice. M.: Prackticheskaya medicina; 2012. (In Russ.).
  23. Zaytsev VM, Liflyandskiy VG, Marinkin VI. Applied medical statistics, Zdravookhranenie. 2006. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.